Glenmark Pharma Q1FY26 profit slumps 86% to ₹47 cr, revenue down 5%

Revenue from operations fell by 5.1 per cent to ₹3,059.33 crore in Q1FY26 from ₹3,223.30 crore in Q1FY25

​Revenue from operations fell by 5.1 per cent to ₹3,059.33 crore in Q1FY26 from ₹3,223.30 crore in Q1FY25